GSK2982772,
1622848-92-3,
UNII-T5W3M0VO9B,
T5W3M0VO9B,
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide,
GSK-2982772,
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide,
3-Benzyl-N-[(3s)-5-Methyl-4-Oxo-2,3,4,5-Tetrahydro-1,5-Benzoxazepin-3-Yl]-1h-1,2,4-Triazole-5-Carboxamide,
LYPAFUINURXJSG-AWEZNQCLSA-N,
GTPL9554,
CHEMBL4071864,
SCHEMBL15956219,
5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide,
EX-A2558,
s8484,
AKOS030528033,
ACN-041458,
compound 5 [PMID: 28151659],
CS-6899,
GSK 2982772,
AC-29894,
AS-35128,
HY-101760,
J3.650.802G,
(S)-3-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-5-carboxamide,
1H-1,2,4-Triazole-5-carboxamide, 3-(phenylmethyl)-N-((3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl)-,
7MJ,
N/A,